Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations

Cancer Research

Volumn 74, Issue 3, 2014, Pages 818-828

  Mueller, Claudius ^a   De Carvalho, Ana C ^b   Mikkelsen, Tom ^b   Lehman, Norman L ^b   Calvert, Valerie ^a   Espina, Virginia ^a   Liotta, Lance A ^a   Petricoin, Emanuel F ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NEOPLASMS; CLUSTER ANALYSIS; DRUG DISCOVERY; GENETIC ASSOCIATION STUDIES; GENOMICS; GLIOBLASTOMA; HUMANS; MUTATION; PHENOTYPE; PHOSPHOPROTEINS; PROTEIN INTERACTION MAPPING; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84893836999     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2172     Document Type: Article

References (34)

1. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008;18:27-34.
2. Xing F, Saidou J, Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 2010;15:166-79.
3. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia 2011;59:1169-80.
4. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, et al. Laser capture microdissection. Science 1996;274: 998-001.
5. Espina V, Wulfkuhle J, Liotta LA. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment. Clin Lab Med 2009;29:1-13.
6. Liu A. Laser capture microdissection in the tissue biorepository. J Biomol Tech 2010;21:120-5.
7. Cheng L, Zhang S, Maclennan GT, Williamson SR, Davidson DD, Wang M, et al. Laser-assisted microdissection in translational research: theory, technical considerations, and future applications. Appl Immunohistochem Mol Morphol 2012;21:31-47.
8. Cohen P, Alessi DR. Kinase drug discovery-what's next in the field? ACS Chem Biol 2013;8:96-104.
9. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001;20:1981-9.
10. Mueller C, Liotta LA, Espina V. Reverse phase protein microarrays advance to use in clinical trials. Mol Oncol 2010;4:461-81.
11. Silvestri A, Colombatti A, Calvert VS, Deng J, Mammano E, Belluco C, et al. Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Invest 2010;90:787-96.
12. Wulfkuhle JD, Speer R, Pierobon M, Laird J, Espina V, Deng J, et al. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 2008;7: 1508-17.
13. The Cancer Genome Atlas [cited 2013 Oct 28]. Available from: http://cancergenome.nih.gov; accessed October 28, 2013.
14. Garber K. Human cancer genome project moving forward despite some doubts in community. J Natl Cancer Inst 2005;97:1322-4.
15. The Cancer Genome Atlase (TCGA) Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-8.
16. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2: 401-4.
17. Gallagher RI, Blakely SR, Liotta LA, Espina V. Laser capture microdissection: Arcturus(XT) infrared capture and UV cutting methods. Methods Mol Biol 2012;823:157-78.
18. Brat DJ, Prayson RA, Ryken TC, Olson JJ. Diagnosis of malignant glioma: role of neuropathology. J Neurooncol 2008;89:287-311.
19. Chiechi A, Mueller C,BoehmKM, RomanoA, BenassiMS, Picci P, et al. Improved data normalization methods for reverse phase protein microarray analysis of complex biological samples. BioTechniques 2012; 0:1-7.
20. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
21. Oliphant TE. Python for scientific computing. Comput Sci Eng 2007;9:10-20.
22. Liu TF, Tatter SB, Willingham MC, Yang M, Hu JJ, Frankel AE. Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy. Mol Cancer Ther 2003;2: 783-7.
23. Lee JC, Vivanco I, Beroukhim R, Huang JHY, Feng WL, DeBiasi RM, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med 2006;3:e485.
24. Endoh H, Ishibashi Y, Yamaki E, Yoshida T, Yajima T, Kimura H, et al. Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutation. Lung Cancer 2009;63:241-6.
25. Comincini S, Paolillo M, Barbieri G, Palumbo S, Sbalchiero E, Azzalin A, et al. Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens. J Biol Biotechnol 2009;2009:1-13.
26. Mladkova N, Chakravarti A. Molecular profiling in glioblastoma: prelude to personalized treatment. Curr Oncol Rep 2009;11:53-61.
27. Federici G, Gao X, Slawek J, Arodz T, Shitaye A, Wulfkuhle JD, et al. Systems analysis of the NCI-60 cancer cell lines by alignment of protein pathway activation modules with "-OMIC" data fields and therapeutic response signatures. Mol Cancer Res 2013;11:676-85.
28. Wulfkuhle JD, Berg D, Wolff C, Langer R, Tran K, Illi J, et al. Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin Cancer Res 2012;18: 6426-35.
29. Sheehan KM, Gulmann C, Eichler GS, Weinstein JN, Barrett HL, Kay EW, et al. Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene 2008;27:323-31.
30. Gimm O, Attie-Bitach T, Lees JA, Vekemans M, Eng C. Expression of the PTEN tumour suppressor protein during human development. Hum Mol Genet 2000;9:1633-9.
31. Zuurbier L, Petricoin EF, Vuerhard MJ, Calvert V, Kooi C, Buijs-Gladdines J, et al. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica 2012; 97:1405-13.
32. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 2000; 21:2235-42.
33. The Cancer Genome Atlas [cited 2013 Oct 28]. Available from: http://cancergenome.nih.gov/cancersselected/biospeccriteria; accessed October 28, 2013.
34. Espina VA, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, et al. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 2008;7:1998-2018.